KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

McEwen (MUX) Research & Development (2016 - 2025)

Historic Research & Development for McEwen (MUX) over the last 14 years, with Q3 2025 value amounting to $6.8 million.

  • McEwen's Research & Development rose 2719.08% to $6.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $18.2 million, marking a year-over-year increase of 160.67%. This contributed to the annual value of $16.5 million for FY2024, which is 1795.51% down from last year.
  • According to the latest figures from Q3 2025, McEwen's Research & Development is $6.8 million, which was up 2719.08% from $5.4 million recorded in Q2 2025.
  • McEwen's Research & Development's 5-year high stood at $6.9 million during Q2 2021, with a 5-year trough of $2.4 million in Q4 2024.
  • For the 5-year period, McEwen's Research & Development averaged around $4.7 million, with its median value being $4.7 million (2023).
  • Its Research & Development has fluctuated over the past 5 years, first surged by 9492.67% in 2021, then plummeted by 3792.65% in 2022.
  • Over the past 5 years, McEwen's Research & Development (Quarter) stood at $4.5 million in 2021, then fell by 21.08% to $3.5 million in 2022, then rose by 5.65% to $3.7 million in 2023, then plummeted by 36.86% to $2.4 million in 2024, then soared by 186.96% to $6.8 million in 2025.
  • Its Research & Development was $6.8 million in Q3 2025, compared to $5.4 million in Q2 2025 and $3.7 million in Q1 2025.